Back
Sarepta Therapeutics Stock Price Chart
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Sell
31
SRPT
Sarepta Therapeutics
Last Price:
124.92
Seasonality Move:
11.13%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Sarepta Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 127.08 | Sell |
| 20-day SMA: | 126 | Sell |
| 50-day SMA: | 127.18 | Sell |
| 200-day SMA: | 130.57 | Sell |
| 8-day EMA: | 125.96 | Sell |
| 20-day EMA: | 126.26 | Sell |
| 50-day EMA: | 128.02 | Sell |
| 200-day EMA: | 127.82 | Sell |
Sarepta Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 46.43 | Sell |
| Chaikin Money Flow: | 728345 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (120.8 - 128.94) | Buy |
| Bollinger Bands (100): | (123.42 - 147.2) | Sell |
Sarepta Therapeutics Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sarepta Therapeutics Stock
Is Sarepta Therapeutics Stock a Buy?
- Sarepta Therapeutics share price is 125.01 while SRPT 8-day simple moving average is 127.08, which is a Sell signal.
- The stock price of SRPT is 125.01 while Sarepta Therapeutics 20-day SMA is 126.00, which makes it a Sell.
- Sarepta Therapeutics 50-day simple moving average is 127.18 while SRPT share price is 125.01, making it a Sell technically.
- SRPT stock price is 125.01 and Sarepta Therapeutics 200-day simple moving average is 130.57, creating a Sell signal.
SRPT Technical Analysis vs Fundamental Analysis
Sell
31
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy or a Sell?
-
Sarepta Therapeutics stock is rated a Sell
The current Sarepta Therapeutics [SRPT] share price is $125.01. The Score for SRPT is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
Sarepta Therapeutics Stock Info
Market Cap:
11.92B
Price in USD:
125.01
Share Volume:
825.63K
Sarepta Therapeutics 52-Week Range
52-Week High:
173.25
52-Week Low:
75.85
Sell
31
Sarepta Therapeutics (SRPT)
is a Sell
Sarepta Therapeutics Share Price Forecast
-
What is the Sarepta Therapeutics stock price today?
The Sarepta Therapeutics stock price is 125.01 USD today. -
Will SRPT stock go up or go down?
Sarepta Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Sarepta Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sarepta Therapeutics is overvalued.
Is Sarepta Therapeutics Stock a Buy?
- Sarepta Therapeutics share price is 125.01 while SRPT 8-day exponential moving average is 125.96, which is a Sell signal.
- The stock price of SRPT is 125.01 while Sarepta Therapeutics 20-day EMA is 126.26, which makes it a Sell.
- Sarepta Therapeutics 50-day exponential moving average is 128.02 while SRPT share price is 125.01, making it a Sell technically.
- SRPT stock price is 125.01 and Sarepta Therapeutics 200-day simple moving average is 127.82, creating a Sell signal.
Fundamental Analysis of Sarepta Therapeutics
Is Sarepta Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $2.72 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.19 per share, and an increase next year of $8.77 per share.
Technical Analysis of Sarepta Therapeutics
Should I short Sarepta Therapeutics stock?
- SRPT Moving Average Covergence Divergence (MACD) indicator is -0.16, suggesting Sarepta Therapeutics is a Sell
- Sarepta Therapeutics Relative Strength Index (RSI) is 46.43, which suggest Sarepta Therapeutics is oversold
- The Bollinger Bands (25) for Sarepta Therapeutics is (120.8 - 128.94), which suggest Sarepta Therapeutics is a Sell
- The Bollinger Bands (100) for Sarepta Therapeutics is (123.42 - 147.2), which suggest Sarepta Therapeutics is a Sell
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.